Evaluation and Classification Risks of Implementing Blockchain in the Drug Supply Chain with a New Hybrid Sorting Method

Parisa Sabbagh, Rana Pourmohamad, Marischa Elveny, Mohammadali Beheshti, Afshin Davarpanah, Ahmed Sayed M. Metwally, Shafaqat Ali and Amin Salih Mohammed
Additional contact information
Parisa Sabbagh: DISA-MIS Department, University of Salerno, 84084 Fisciano, Italy
Rana Pourmohamad: ASU School of Computing, Informatics, and Decision System Engineering, Arizona State University, Tempe, AZ 85281, USA
Marischa Elveny: Department of Data Science & Computational Intelligence Research Group, Universitas Sumatera Utara, Medan 20222, Indonesia
Mohammadali Beheshti: University of Houston-Clear Lake, Department of Science and Engineering, Houston, TX 77058, USA
Afshin Davarpanah: Data Science & Computational Intelligence Research Group, Universitas Medan Area, Medan 20112, Indonesia
Ahmed Sayed M. Metwally: Department of Mathematics, College of Science, King Saud University, Riyadh 11451, Saudi Arabia
Shafaqat Ali: Department of Environmental Science and Engineering, Government College University, Faisalabad 38000, Pakistan
Amin Salih Mohammed: Department of Computer Engineering, College of Engineering and Computer Science, Lebanese French University, Erbil 44001, Kurdistan Region, Iraq

Sustainability, 2021, vol. 13, issue 20, 1-19

Abstract: In blockchain technology, all registered information, from the place of production of the product to its point of sale, is recorded as permanent and unchangeable, and no intermediary has the ability to change the data of other members and even the data registered by them without public consensus. In this way, users can trust the accuracy of the data. Blockchain systems have a wide range of applications in the medical and health sectors, from creating an integrated system for recording and tracking patients’ medical records to creating transparency in the drug supply chain and medical supplies. However, implementing blockchain technology in the supply chain has limitations and sometimes has risks. In this study, BWM methods and VIKORSort have been used to classify the risks of implementing blockchain in the drug supply chain. The results show that cyberattacks, double spending, and immutability are very dangerous risks for implementation of blockchain technology in the drug supply chain. Therefore, the risks of blockchain technology implementation in the drug supply chain have been classified based on a literature review and opinions of the experts. The risks of blockchain technology implementation in the supply chain were determined from the literature review.

Keywords: blockchain; VIKORSort; BWM; MCDM; supply chain; health supply chain (search for similar items in EconPapers)
JEL-codes: O13 Q Q0 Q2 Q3 Q5 Q56 (search for similar items in EconPapers)
Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.mdpi.com/2071-1050/13/20/11466/pdf (application/pdf)
https://www.mdpi.com/2071-1050/13/20/11466/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jsusta:v:13:y:2021:i:20:p:11466-:d:658474

Access Statistics for this article

Sustainability is currently edited by Ms. Alexandra Wu

More articles in Sustainability from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().